In the human body, sulfoxides can be metabolized through several pathways. One common route is the further oxidation to sulfones, which involves the incorporation of an additional oxygen atom. Additionally, sulfoxides can be reduced back to thioethers. The balance between these oxidative and reductive pathways can influence the pharmacokinetics and toxicity of compounds containing sulfoxide moieties.
